1 Min Read
Feb 23 (Reuters) - Wilson Therapeutics AB:
* Q4 operating loss 32.9 million Swedish crowns ($3.7 million)versus loss 21.3 million crowns year ago Source text for Eikon:
Further company coverage: ($1 = 8.9778 Swedish crowns) (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.